Inflammation in cardiac amyloidosis: prognostic marker or therapeutic target?

被引：2
|
作者：
Sinagra, Gianfranco [1 ,2 ]
Fabris, Enrico [1 ,2 ]
机构：
[1] Univ Trieste, Dept Med Surg & Hlth Sci, Str Fiume 447, I-34149 Trieste, Italy
[2] Azienda Sanit Univ Integrata Trieste, Ctr Translat Cardiol, Trieste, Italy
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2018年 / 20卷 / 04期
关键词：
PRIMARY SYSTEMIC AMYLOIDOSIS; LIGHT-CHAIN AMYLOIDOSIS; STAGING SYSTEM;
D O I：
10.1002/ejhf.1062
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：758 / 759
页数：2
相关论文
共 50 条
  • [21] CD38 AT THE JUNCTION BETWEEN PROGNOSTIC MARKER AND THERAPEUTIC TARGET
    Malavasi, Fabio
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2012, 82B (06) : 378 - 378
  • [22] Interface hepatitis in primary biliary cirrhosis:: prognostic marker and therapeutic target
    Poupon, R.
    Abenavoli, L.
    Rabahi, N.
    Chretien, Y.
    Chazouilleres, O.
    Wendum, D.
    Corpechot, C.
    Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune, 2007, 157 : 66 - 74
  • [23] Proteinuria in chronic kidney disease in cats - Prognostic marker or therapeutic target?
    Elliott, Jonathan
    Syme, Harriet M.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2006, 20 (05) : 1052 - 1053
  • [24] Potential prognostic marker and therapeutic target for oesophageal squamous cell carcinoma?
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 (9) : 488 - 488
  • [25] 14-3-3ζ as a prognostic marker and therapeutic target for cancer
    Neal, Christopher L.
    Yu, Dihua
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (12) : 1343 - 1354
  • [26] Bcl-xL as prognostic marker and potential therapeutic target in cholangiocarcinoma
    Hoffmeister-Wittmann, Paula
    Mock, Andreas
    Nichetti, Federico
    Korell, Felix
    Heilig, Christop E.
    Scherr, Anna-Lena
    Gunther, Michael
    Albrecht, Thomas
    Kelmendi, Eblina
    Xu, Kaiyu
    Nader, Luisa
    Kessler, Annika
    Schmitt, Nathalie
    Fritzsche, Sarah
    Weiler, Sofia
    Sobol, Benjamin
    Stenzinger, Albrecht
    Boeck, Stefan
    Westphalen, Christoph B.
    Schulze-Osthoff, Klaus
    Trojan, Jorg
    Kindler, Thomas
    Weichert, Wilko
    Spiekermann, Karsten
    Bitzer, Michael
    Folprecht, Gunnar
    Illert, Anna-Lena
    Boerries, Melanie
    Klauschen, Frederick
    Ochsenreiter, Sebastian
    Siveke, Jens
    Bauer, Sebastian
    Glimm, Hanno
    Brors, Benedikt
    Huellein, Jennifer
    Huebschmann, Daniel
    Uhrig, Sebastian
    Horak, Peter
    Kreutzfeld, Simon
    Banales, Jesus M.
    Springfeld, Christoph
    Jaeger, Dirk
    Schirmacher, Peter
    Roessler, Stephanie
    Ormanns, Steffen
    Goeppert, Benjamin
    Froehling, Stefan
    Koehler, Bruno C.
    LIVER INTERNATIONAL, 2022, 42 (12) : 2855 - 2870
  • [27] CWH43 as a prognostic marker and therapeutic target in colorectal cancer
    Lee, Cheng-Chin
    Chang, Yu-Jia
    Huang, Chien-Yu
    CANCER RESEARCH, 2024, 84 (07)
  • [28] NF-κB as a prognostic marker and therapeutic target in prostate cancer
    Vykhovanets, Eugene
    Shankar, Eswar
    Shukla, Sanjeev
    Vykhovanets, Olena
    MacLennan, Gregory T.
    Gupta, Sanjay
    CANCER RESEARCH, 2015, 75
  • [29] Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer
    Furukawa, C
    Daigo, Y
    Ishikawa, N
    Kato, T
    Ito, T
    Tsuchiya, E
    Sone, S
    Nakamura, Y
    CANCER RESEARCH, 2005, 65 (16) : 7102 - 7110
  • [30] CCR9 as a prognostic marker and therapeutic target in hepatocellular carcinoma
    Zhang, Zhenhai
    Qin, Chengkun
    Wu, Yaguang
    Su, Zhongxue
    Xian, Guozhe
    Hu, Bo
    ONCOLOGY REPORTS, 2014, 31 (04) : 1629 - 1636
12345